What Pfizer's 8-K filings say: 4 filings, latest Nov 3, 2026
Pfizer filed its latest 8-K with the SEC on Nov 3, 2026. It discusses CFO change.
Public (PFE)Pharmaceutical Manufacturing10,000+ employeespfizer.comLinkedIn
Get Pfizer's live signals in Claude or ChatGPT, or by API
What changed at Pfizer this week? Use Autobound signals for pfizer.com.- Filed
- Nov 3, 2026
- Filings
- 4
- Signals
- 7
Source: Autobound Signal API · 104 signals tracked for Pfizer · updated
8-K · latest 7
What Pfizer's 8-K filings say
- SEC EDGAR
8-K
Filed · 1 signal
Pfizer Appoints Cecile Guegan as Chief Financial Officer Effective November 1, 2026
Pfizer's Board of Directors unanimously elected Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026, with an annual base salary of $1,300,000.
- SEC EDGAR
8-K
Filed · 2 signals
Prevnar Family Revenues Fell 10% Operationally Due to Market Share Erosion in U.S. Adult Indication
Pfizer reported that third-quarter 2026 Prevnar family revenues dropped $180 million or 10% operationally, driven in part by adult indication market share erosion in the U.S.
$180M
operational revenue decrease for Prevnar family globally
-10%
operational revenue decrease for Prevnar family globally
Paxlovid Revenues Dropped 63% Operationally to $771 Million on Lower COVID-19 Infection Demand
Pfizer's Paxlovid global revenues fell by $771 million, or 63% operationally, driven by reduced COVID-19 infection rates across U.S.
$771M
operational revenue decline for Paxlovid globally
-63%
operational revenue decline for Paxlovid globally
- SEC EDGAR
8-K
Filed · 2 signals
Pfizer announces CFO transition on June 18, 2026, signaling potential financial strategy review.
A change in the Chief Financial Officer role is a major catalyst for reviewing financial strategies, processes, and technology stacks.
Pfizer reports continued decline in demand for its COVID-19 products, Comirnaty and Paxlovid.
Reduced demand for major COVID-19 products is leading to lower revenues and potential excess inventory charges, creating pressure to improve operational efficiency.
- SEC EDGAR
8-K
Filed · 2 signals
Pfizer CFO Dave Denton to depart on August 15, 2026; interim CFO named during search for successor.
The appointment of an interim CFO, Cecile Guegan, and the active search for a permanent replacement often leads to re-evaluation of financial systems, reporting tools, and advisory services.
Pfizer CFO Dave Denton to step down August 15; Cecile Guegan named Interim CFO
Signal API · MCP
Track Pfizer with the Signal API
One POST /v1/companies/enrich call with pfizer.com returns Pfizer 8-K signals (sec-8k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"pfizer.com","signal_types":["sec-8k"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 8-K Filings records, as a CSV.
Same industry
8-K at related companies
Questions about Pfizer 8-K
When did Pfizer file its latest 8-K?
What did Pfizer disclose in its latest 8-K?
Where can I read Pfizer's 8-K filing?
Page updated , the date of the newest row on this page.
Source. Current reports (Form 8-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .